Advanced search
Publication Cover
Expert Opinion on Drug Metabolism & Toxicology Volume 15, 2019 - Issue 3
Submit an article Journal homepage
811
Views
17
CrossRef citations to date
0
Altmetric
Review

Pharmacokinetics and pharmacodynamics of new acute treatments for migraine

Chiara LupiHeadache Centre, Careggi University Hospital, Health Sciences Department, University of Florence, Florence, ItalyCorrespondence[email protected]
View further author information
,
Silvia BenemeiHeadache Centre, Careggi University Hospital, University of Florence, Florence, ItalyView further author information
,
Simona GuerzoniMedical Toxicology, Headache and Drug Abuse Center, University of Modena and Reggio Emilia, Modena, ItalyView further author information
,
Lanfranco PellesiMedical Toxicology, Headache and Drug Abuse Center, University of Modena and Reggio Emilia, Modena, ItalyView further author information
&
Andrea NegroRegional Referral Headache Centre, Sant’Andrea Hospital, Department of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, ItalyView further author information
Pages 189-198 | Received 19 Dec 2018, Accepted 01 Feb 2019, Published online: 12 Feb 2019

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Silvia Benemei, Enrico Bentivegna & Paolo Martelletti. (2022) Positioning the new drugs for migraine. Expert Opinion on Drug Metabolism & Toxicology 18:1, pages 1-3.
Read now
Martina Curto, Fabiola Cipolla, Giusy Ylenia Cisale, Matilde Capi, Valerio Spuntarelli, Martina Guglielmetti, Paolo Martelletti & Luana Lionetto. (2020) Profiling lasmiditan as a treatment option for migraine. Expert Opinion on Pharmacotherapy 21:2, pages 147-153.
Read now
Andrea Negro & Paolo Martelletti. (2019) Patient selection for migraine preventive treatment with anti-CGRP(r) monoclonal antibodies. Expert Review of Neurotherapeutics 19:8, pages 769-776.
Read now

Articles from other publishers (14)

Amnon A. Berger, Joseph Keefe, Cain W. Stark, Matthew Moore, Giovanni F. Ramírez, Julia R. Cucarola, Andrew H. Han, Alan D. Kaye & Latha Ganti. (2022) Eptinezumab-jjmr, a humanized monoclonal specific to Calcitonin Gene Related Peptide, for the preventive treatment of migraine in adults. Health Psychology Research 10:5.
Crossref
Mónica Rueda Vega, Alicia Martínez-Fernández, Sonia Quintas, Javier Díaz de Terán, Germán Latorre González, Olga Trabajos García, Jose Vivancos Mora & Ana Beatriz Gago-Veiga. (2022) “The Triptan's Hangover”: A Multicentric Cross-sectional Observational Study of the Adverse Events of Triptans in Patients With Migraine. Clinical Neuropharmacology 45:2, pages 21-26.
Crossref
Simonetta Cristina Di Simone, Alessandra Acquaviva, Maria Loreta Libero, Annalisa Chiavaroli, Lucia Recinella, Sheila Leone, Luigi Brunetti, Matteo Politi, Claudia Giannone, Claudia Campana, Giustino Orlando, Gokhan Zengin, Massimo Tacchini, Luigi Menghini & Claudio Ferrante. (2022) The Association of Tanacetum parthenium and Salix alba Extracts Reduces Cortex Serotonin Turnover, in an Ex Vivo Experimental Model of Migraine. Processes 10:2, pages 280.
Crossref
Linda Al-Hassany & Antoinette MaassenVanDenBrink. (2021) Drug interactions and risks associated with the use of triptans, ditans and monoclonal antibodies in migraine. Current Opinion in Neurology 34:3, pages 330-338.
Crossref
Peter J Goadsby, Andrew M Blumenfeld, Richard B Lipton, David W Dodick, Kavita Kalidas, Aubrey M Adams, Abhijeet Jakate, Chengcheng Liu, Armin Szegedi & Joel M Trugman. (2020) Time course of efficacy of ubrogepant for the acute treatment of migraine: Clinical implications. Cephalalgia 41:5, pages 546-560.
Crossref
Anna Ferrari & Cecilia Rustichelli. (2021) Rational Use of Lasmiditan for Acute Migraine Treatment in Adults: A Narrative Review. Clinical Therapeutics 43:4, pages 654-670.
Crossref
Lucia Recinella, Annalisa Chiavaroli, Viviana di Giacomo, Marco Daniel Antolini, Alessandra Acquaviva, Sheila Leone, Luigi Brunetti, Luigi Menghini, Gunes Ak, Gokhan Zengin, Simonetta Cristina Di Simone, Claudio Ferrante & Giustino Orlando. (2020) Anti-Inflammatory and Neuromodulatory Effects Induced by Tanacetum parthenium Water Extract: Results from In Silico, In Vitro and Ex Vivo Studies. Molecules 26:1, pages 22.
Crossref
Danuta Szkutnik-Fiedler. (2020) Pharmacokinetics, Pharmacodynamics and Drug–Drug Interactions of New Anti-Migraine Drugs—Lasmiditan, Gepants, and Calcitonin-Gene-Related Peptide (CGRP) Receptor Monoclonal Antibodies. Pharmaceutics 12:12, pages 1180.
Crossref
Giovanna Casili, Marika Lanza, Alessia Filippone, Michela Campolo, Irene Paterniti, Salvatore Cuzzocrea & Emanuela Esposito. (2020) Dimethyl fumarate alleviates the nitroglycerin (NTG)-induced migraine in mice. Journal of Neuroinflammation 17:1.
Crossref
Jill C Rau, Edita Navratilova, Janice Oyarzo, Kirk W Johnson, Sheena K Aurora, Todd J Schwedt, David W Dodick & Frank Porreca. (2020) Evaluation of LY573144 (lasmiditan) in a preclinical model of medication overuse headache. Cephalalgia 40:9, pages 903-912.
Crossref
Max Tsai, Michael Case, Paul Ardayfio, Helen Hochstetler & Darren Wilbraham. (2020) Effects of Lasmiditan on Cardiovascular Parameters and Pharmacokinetics in Healthy Subjects Receiving Oral Doses of Propranolol. Clinical Pharmacology in Drug Development 9:5, pages 629-638.
Crossref
Sunhee Kim & In-hwan Baek. (2019) Meta-analysis on the Efficacy of Glutamate Receptor Antagonists for Acute Migraine Treatment. Korean Journal of Clinical Pharmacy 29:4, pages 247-253.
Crossref
Viviana di Giacomo, Claudio Ferrante, Maurizio Ronci, Amelia Cataldi, Valentina Di Valerio, Monica Rapino, Lucia Recinella, Annalisa Chiavaroli, Sheila Leone, Sanda Vladimir-Knežević, Marija Kindl, Luigi Brunetti, Luigi Menghini & Giustino Orlando. (2019) Multiple pharmacological and toxicological investigations on Tanacetum parthenium and Salix alba extracts: Focus on potential application as anti-migraine agents. Food and Chemical Toxicology 133, pages 110783.
Crossref
Kelemen Hajnal, Filep Bíborka-Erzsébet & Papp Lajos Attila. (2019) Chemical and pharmacological characterization of triptans. Bulletin of Medical Sciences 92:1, pages 53-60.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.